{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-055829","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.379826+00:00","generated_at":"2026-06-15T21:51:48.186360+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"iSpecimen reports Q1 revenue of $3.0M (+17% YoY); net loss flat at $2.4M","bullets":["Revenue $3.0M vs $2.5M in Q1 2022, a 17% increase; specimen count up 75% but ASP down 30%.","Net loss $2.4M ($0.27 per share), unchanged YoY; cash, equivalents and securities totaled $11M at Mar 31 vs $15.3M at Dec 31.","Unique customer organizations reached 534 (+22%); registered marketplace users ~6,900 (+24%).","CEO Tracy Curley cited progress on adjacent revenue opportunities and technology investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-055829","json":"https://secwatch.observer/filing/0001104659-23-055829.json","markdown":"https://secwatch.observer/filing/0001104659-23-055829.md","text":"https://secwatch.observer/filing/0001104659-23-055829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923055829/0001104659-23-055829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923055829/tm2314591d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T21:51:48.186360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"120c1e6e222d51ce99d94bca23203f4f17b3f3a4","claim":"iSpecimen Inc. reported first quarter of 2023 results: revenue Revenue was approximately $3.0 million, net income Net loss was approximately $2.4 million, or $(0.27) per share, EPS $(0.27) per share.","evidence_excerpt":"reported its financial and operating results for the three-month period ended March 31, 2023. “I am pleased to report that iSpecimen delivered strong revenue of approximately $3.0 million, a 17% increase year-over-year for the first quarter of 2023, which met our internal expectations and reflects the seasonality of our business,” said Tracy Curley, CEO and CFO.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923055829/0001104659-23-055829-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of 2023"},{"label":"Revenue","value":"Revenue was approximately $3.0 million"},{"label":"Net income","value":"Net loss was approximately $2.4 million, or $(0.27) per share"},{"label":"EPS","value":"$(0.27) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}